戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 873761作成日:2026年10月25日

Methane → 6'-(2-Fluoro-5-methylpyridin-3-yl)trispiro[cyclobutane-1,2'-chromene-4',4''-[1,3]oxazole-3',3'''-oxetan]-2''-amine

https://huagongshe.com/reaction/873761

反応式

関与物質

役割名称HCID仕込み量
反応物MethaneHCID 297—
反応物Sodium CarbonateHCID 10340—
反応物Potassium AcetateHCID 517044—
反応物Bis(pinacolato)diboraneHCID 2733548—
反応物3-Bromo-2-fluoro-5-methylpyridineHCID 21816563—
反応物Di-tert-butyl (6'-bromotrispiro[cyclobutane-1,2'-chromene-4',4''-[1,3]oxazole-3',3'''-oxetan]-2''-yl)imidodicarbonateHCID 86724300—
触媒HCID 178418476HCID 178418476—
溶媒WaterHCID 962—
溶媒TolueneHCID 1140—
溶媒1,4-DioxaneHCID 31275—
生成物6'-(2-Fluoro-5-methylpyridin-3-yl)trispiro[cyclobutane-1,2'-chromene-4',4''-[1,3]oxazole-3',3'''-oxetan]-2''-amineHCID 9002677861.9%

反応条件

温度100 °C

反応手順

A mixture of 3-bromo-2-fluoro-5-methylpyridine (202 mg, 1.06 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane (300 mg, 1.17 mmol), potassium acetate (208 mg, 2.12 mmol) and PdCl2(PPh3)2 (37 mg, 0.053 mmol) in dioxane (4 mL) was stirred for 3 hours at 100° C. To the mixture was added di-tert-butyl (6′-bromotrispiro[cyclobutane-1,2′-chromene-4′,4″-[1,3]oxazole-3′,3′″-oxetan]-2″-yl)imidodicarbonate (300 mg, 0.531 mmol), sodium carbonate (225 mg, 2.12 mmol) and H2O (1 mL), and the mixture was stirred for 1.5 hours at 100° C. The mixture was treated with charcoal, and filtered off. The filtrate was partitioned between EtOAc and water. The organic layer was washed with brine, dried over MgSO4, filtered, and the filtrate was evaporated to give a pale brown oil. The oil was dissolved in toluene (5 mL) and to the mixture was added silicagel (neutral; 600 mg). The mixture was refluxed for 1 hour. The solvent was evaporated off. Silicagel column chromatography (CHCl3-EtOH, linear gradient of EtOH from 0 to 20%) afforded a solid. The solid was triturated in Et2O and collected by filtration, washed with Et2O and dried in vacuo at 70° C. to give 6′-(2-fluoro-5-methylpyridin-3-yl)trispiro[cyclobutane-1,2′-chromene-4′,4″-[1,3]oxazole-3′,3′″-oxetan]-2″-amine (130 mg).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08975415B2
出典データセットuspto-grants-2015_03
ORD IDord-6f5290830a3244b1b036cf0baf615bd9
出典メモuspto-grants-2015_03